The addition of Genmab's Epkinly to a standard cocktail of drugs helped lymphoma patients live longer before worsening. Genmab stock rocketed. The post AbbVie Partner Flies Sky-High On News For Its $3 Billion Cancer Contender appeared first on Investor's Business Daily.
CryptoAlerta — análise de criptomoedas e mercado em tempo real